OrthoPediatrics

OrthoPediatrics Launches FDA-Cleared VerteGlide System for Early Onset Scoliosis Treatment

- OrthoPediatrics has received FDA clearance for the VerteGlide Spinal Growth Guidance System, designed specifically to treat Early Onset Scoliosis in children under 10 years of age. - The innovative system aims to correct spinal deformities while minimizing the need for repeat surgeries until skeletal maturity, addressing a critical need for children suffering from pulmonary and digestive dysfunction. - Initial surgeries with the VerteGlide system are expected to begin this summer at select children's centers, marking the company's 80th system for pediatric musculoskeletal conditions.